SECOND AMENDED AND RESTATED ENGAGEMENT LETTEREngagement Letter • December 16th, 2016 • Stocosil Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 16th, 2016 Company Industry JurisdictionThis second amended and restated engagement letter (the “Agreement”) confirms the terms upon which Stocosil Inc. (the “Client”) engages Boustead Securities, LLC (f/k/a Monarch Bay Securities, LLC) (“Boustead” or the “Placement Agent”). The Placement Agent is engaged to act as the exclusive placement agent to the Client in connection with a Financing (as defined below) of securities on behalf of the Client. The Placement Agent is also the “Financial Adviser,” which the Client hereby engages upon signing this Agreement. This Agreement amends, restates and supersedes in its entirety that certain Amended and Restated Engagement Letter dated September 19, 2016 between the Client and the Placement Agent (the “Original Letter”).
SECOND AMENDED AND RESTATED ENGAGEMENT LETTEREngagement Letter • November 14th, 2016 • Stocosil Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 14th, 2016 Company Industry JurisdictionThis second amended and restated engagement letter (the “Agreement”) confirms the terms upon which Stocosil Inc. (the “Client”) engages Boustead Securities, LLC (f/k/a Monarch Bay Securities, LLC) (“Boustead” or the “Placement Agent”). The Placement Agent is engaged to act as the exclusive placement agent to the Client in connection with a Financing (as defined below) of securities on behalf of the Client. The Placement Agent is also the “Financial Adviser,” which the Client hereby engages upon signing this Agreement. This Agreement amends, restates and supersedes in its entirety that certain Amended and Restated Engagement Letter dated September 19, 2016 between the Client and the Placement Agent (the “Original Letter”).